ArticlePloS one2015

Rapamycin Enhances the Anti-Cancer Effect of Dasatinib by Suppressing Src/PI3K/mTOR Pathway in NSCLC Cells.

Bin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.